Arkolith/Insider Trading/BDSX/Form 4

O'Kane Kieran

Chief Commercial OfficerBIODESIX INC (BDSX) · full profile →Form 4 · filed Aug 14, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$200
Net Open-Market Flow
-$200
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 13, 2025Sell(S)476$0.42$200140K
Aug 12, 2025Option exercise(M)1K——141K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 12, 2025Option exercise(M)1K—$03K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000905148-25-002982) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML